Continuous infusion of angiopeptin significantly reduces accelerated graft vessel disease induced by FK 506 in a rat heart allograft model

Transplant Proc. 1992 Oct;24(5):1671-2.

Authors

B M Meiser¹, S Wolf, C Devens, K Wenke, J Thiery, E Kreuzer, C Hammer, M E Billingham, B Reichart

Affiliation

¹ Department of Cardiac Surgery, Ludwig Maximilians University of Munich, Germany.

PMID: 1384201

No abstract available

Publication types

Comparative Study

MeSH terms

Animals
Coronary Vessels / drug effects*
Coronary Vessels / pathology
Graft Rejection*
Graft Survival / drug effects
Heart Transplantation / immunology*
Heart Transplantation / pathology*
Infusions, Intravenous
Injections, Subcutaneous
Oligopeptides / administration & dosage
Oligopeptides / pharmacology*
Peptides, Cyclic
Rats
Rats, Inbred BN
Rats, Inbred Lew
Somatostatin / administration & dosage
Somatostatin / analogs & derivatives*
Somatostatin / pharmacology
Tacrolimus / toxicity*
Transplantation, Homologous
Transplantation, Isogeneic

Substances

Oligopeptides
Peptides, Cyclic
lanreotide
Somatostatin
Tacrolimus